Ioonikanal (Estonian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ioonikanal" in Estonian language version.

refsWebsite

Global rank Estonian rank

11nih.gov

4^th place

14^th place

5doi.org

2^nd place

16^th place

2discoverymedicine.com

low place

2sciencedirect.com

149^th place

130^th place

2asperbio.com

low place

8,611^th place

1springer.com

274^th place

191^st place

1ingentaconnect.com

3,306^th place

5,931^st place

1diabetesjournals.org

low place

1hambaarst.ee

low place

5,877^th place

1eurekaselect.com

low place

asperbio.com

Tsüstiline fibroos http://www.asperbio.com/et/asper-reprogenetics-testid-2/tsustiline-fibroos/
Brugada sündroom http://www.asperbio.com/et/asper-cardiogenetics-testid/brugada-sundroom/

diabetesjournals.org

diabetes.diabetesjournals.org

Luciani, D. S., Gwiazda, K. S., Yang, T. L. B., Kalynyak, T. B., Bychkivska, Y., Frey, M. H., ... & Johnson, J. D. (2009). Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and β-cell death. Diabetes, 58(2), 422–432.http://diabetes.diabetesjournals.org/content/58/2/422

discoverymedicine.com

Clare, J. J. (2010). Targeting ion channels for drug discovery. Discovery medicine, 9(46), 253–260.http://www.discoverymedicine.com/Jeffrey-J-Clare/2010/03/24/targeting-ion-channels-for-drug-discovery/
Clare, J. J. (2010). Targeting ion channels for drug discovery. Discovery medicine, 9(46), 253–260. http://www.discoverymedicine.com/Jeffrey-J-Clare/2010/03/24/targeting-ion-channels-for-drug-discovery/

doi.org

Camerino, D. C., Tricarico, D., & Desaphy, J. F. (2007). Ion channel pharmacology. Neurotherapeutics, 4(2), 184–198. doi:10.1016/j.nurt.2007.01.013. PMID 17395128
Verkman, A. S., & Galietta, L. J. (2009). Chloride channels as drug targets. Nature reviews Drug discovery, 8(2), 153–171. doi:10.1038/nrd2780. PMC 3601949. PMID 19153558
Camerino, D. C., Desaphy, J. F., Tricarico, D., Pierno, S., & Liantonio, A. (2008). 4-Therapeutic Approaches to Ion Channel Diseases. Advances in genetics, 64, 81–145. doi:10.1016/S0065-2660(08)00804-3. ISBN 978-0-12-374621-4. PMID 19161833
Gabashvili, I. S., Sokolowski, B. H., Morton, C. C., & Giersch, A. B. (2007). Ion channel gene expression in the inner ear. Journal of the Association for Research in Otolaryngology, 8(3), 305–328. doi:10.1007/s10162-007-0082-y. PMC 2538437. PMID 17541769
Vicini, S. (1999). New perspectives in the functional role of GABAA channel heterogeneity. Molecular neurobiology, 19(2), 97–110. doi:10.1007/BF02743656. PMID 10371465

eurekaselect.com

Harvey, A. L., & Robertson, B. (2004). Dendrotoxins: structure-activity relationships and effects on potassium ion channels. Current medicinal chemistry, 11(23), 3065–3072.http://www.eurekaselect.com/62870/article

hambaarst.ee

Koorits, U (2006). Lokaalanesteetikumid hambaravis. http://www.hambaarst.ee/artiklid/633/

ingentaconnect.com

Kim, D. (2005). Physiology and pharmacology of two-pore domain potassium channels. Current pharmaceutical design, 11(21), 2717–2736. http://www.ingentaconnect.com/content/ben/cpd/2005/00000011/00000021/art00005

nih.gov

ncbi.nlm.nih.gov

Camerino, D. C., Tricarico, D., & Desaphy, J. F. (2007). Ion channel pharmacology. Neurotherapeutics, 4(2), 184–198. doi:10.1016/j.nurt.2007.01.013. PMID 17395128
Verkman, A. S., & Galietta, L. J. (2009). Chloride channels as drug targets. Nature reviews Drug discovery, 8(2), 153–171. doi:10.1038/nrd2780. PMC 3601949. PMID 19153558
Camerino, D. C., Desaphy, J. F., Tricarico, D., Pierno, S., & Liantonio, A. (2008). 4-Therapeutic Approaches to Ion Channel Diseases. Advances in genetics, 64, 81–145. doi:10.1016/S0065-2660(08)00804-3. ISBN 978-0-12-374621-4. PMID 19161833
Gabashvili, I. S., Sokolowski, B. H., Morton, C. C., & Giersch, A. B. (2007). Ion channel gene expression in the inner ear. Journal of the Association for Research in Otolaryngology, 8(3), 305–328. doi:10.1007/s10162-007-0082-y. PMC 2538437. PMID 17541769
Vicini, S. (1999). New perspectives in the functional role of GABAA channel heterogeneity. Molecular neurobiology, 19(2), 97–110. doi:10.1007/BF02743656. PMID 10371465
Catterall, W. A. (2011). Voltage-gated calcium channels. Cold Spring Harbor perspectives in biology, 3(8), a003947.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140680/
Bowman, C. L., Gottlieb, P. A., Suchyna, T. M., Murphy, Y. K., & Sachs, F. (2007). Mechanosensitive ion channels and the peptide inhibitor GsMTx-4: history, properties, mechanisms and pharmacology. Toxicon, 49(2), 249–270.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852511/
Madamba, S. M., Damri, K. N., Dejean, L. M., & Peixoto, P. M. (2015). Mitochondrial ion channels in cancer transformation. Frontiers in oncology, 5, 120.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455240/
Pottosin, I., & Dobrovinskaya, O. (2015). Ion channels in native chloroplast membranes: challenges and potential for direct patch-clamp studies. Frontiers in physiology, 6.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686732/
Kuo, I. Y., & Ehrlich, B. E. (2012). Ion channels in renal disease. Chemical reviews, 112(12), 6353–6372.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511917/

ghr.nlm.nih.gov

Genetics Home Reference (2016). mucolipidosis type IV https://ghr.nlm.nih.gov/condition/mucolipidosis-type-iv

sciencedirect.com

Wood, J. N., & Baker, M. (2001). Voltage-gated sodium channels. Current opinion in pharmacology, 1(1), 17–21. http://www.sciencedirect.com/science/article/pii/S1471489201000078
Tsai, M. F., & Miller, C. (2014). Building a Temperature-Sensitive Ion Channel. Cell, 158(5), 977–979.http://www.sciencedirect.com/science/article/pii/S0092867414010344

springer.com

link.springer.com

DeCoursey, T. E. (2008). Voltage-gated proton channels. Cellular and Molecular Life Sciences, 65(16), 2554–2573. https://link.springer.com/article/10.1007/s00018-008-8056-8